MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 104 filers reported holding MERUS N V in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $439,367 | -25.8% | 18,633 | -17.2% | 0.00% | – |
| Q2 2023 | $592,372 | +25.5% | 22,498 | -12.3% | 0.00% | – |
| Q1 2023 | $471,868 | +19.8% | 25,645 | +0.7% | 0.00% | – |
| Q4 2022 | $393,944 | +79.1% | 25,465 | +132.2% | 0.00% | – |
| Q3 2022 | $220,000 | -36.6% | 10,969 | -28.4% | 0.00% | – |
| Q2 2022 | $347,000 | -56.7% | 15,314 | -49.4% | 0.00% | – |
| Q1 2022 | $801,000 | +11.2% | 30,288 | +33.7% | 0.00% | – |
| Q4 2021 | $720,000 | +1700.0% | 22,646 | +1136.8% | 0.00% | – |
| Q3 2021 | $40,000 | -18.4% | 1,831 | -21.5% | 0.00% | – |
| Q2 2021 | $49,000 | -16.9% | 2,333 | -17.3% | 0.00% | – |
| Q1 2021 | $59,000 | +103.4% | 2,820 | +72.9% | 0.00% | – |
| Q4 2020 | $29,000 | +20.8% | 1,631 | -17.3% | 0.00% | – |
| Q3 2020 | $24,000 | -25.0% | 1,972 | -2.0% | 0.00% | – |
| Q2 2020 | $32,000 | – | 2,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |